Ss. Winter et al., ELEVATED LEVELS OF TUMOR NECROSIS FACTOR-BETA, GAMMA-INTERFERON, AND IL-6 MESSENGER-RNA IN CASTLEMANS DISEASE, Medical and pediatric oncology, 26(1), 1996, pp. 48-53
Castleman's disease (CD) is a lymphoproliferative disorder characteriz
ed by enlarged hyperplastic lymph nodes. CD may be localized or multif
ocal, and is often associated with signs and symptoms of generalized i
nflammation. The systemic manifestations of CD have been previously at
tributed to an overproduction of interleukin-6 (IL-6) by the tumor, al
though there is evidence that IL-6 is not responsible for all of the s
ymptoms. We describe a 9-year-old boy who developed Castleman's diseas
e with systemic findings of hypochromic microcytic anemia, growth arre
st, inflammation, and hyperimmunoglobulinemia. Following surgical rese
ction, all of the symptoms and laboratory abnormalities resolved. Usin
g reverse transcriptase polymerase chain reaction (RT-PCR) analysis of
the tumor, we found elevated levels of IL-6 mRNA as expected, but als
o elevated levels of tumor necrosis factor beta (TNF-beta) and gamma i
nterferon (gamma-IFN) mRNA. Because these cytokines are mediators of i
mmune regulation and inflammation, we propose that TNF-beta and gamma-
IFN also play an important role in the pathophysiology of Castleman's
disease. (C) 1996 Wiley-Liss, Inc.